HealthStream, Inc.
HealthStream, Inc. (HSTM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
hstm · stock forecast · 16 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Hold
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$24.00
Consensus
$24.00
-6.2% upside
Low
$24.00
Median: $24 · Last Close: $25.59
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $26.26 | ↑ 2.61% |
1-day model range: $26.09–$26.43. Peak: $26.43 (+2.61%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $25 | -3.7% |
| 2028 | $24 | -5.6% |
| 2029 | $24 | -6.7% |
| 2030 | $24 | -7.3% |
| 2031 | — | -7.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HSTM · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-06 | Canaccord Genuity | Maintains | Hold→Hold |
| 2025-12-17 | Canaccord Genuity | Maintains | Hold→Hold |
| 2025-08-07 | Canaccord Genuity | Maintains | Hold→Hold |
| 2025-05-15 | Canaccord Genuity | Maintains | Hold→Hold |
| 2025-02-26 | Canaccord Genuity | Maintains | Hold→Hold |
| 2025-02-06 | JMP Securities | Maintains | Market Perform→Market Perform |
| 2024-10-23 | Canaccord Genuity | Maintains | Hold→Hold |
| 2024-10-23 | Barclays | Maintains | Overweight→Overweight |
| 2024-07-24 | Canaccord Genuity | Maintains | Hold→Hold |
| 2023-02-22 | Canaccord Genuity | Maintains | Hold→Hold |
Wall Street analysts have recently issued updated ratings on HealthStream, Inc. (HSTM) stock. Of the recent 41 rating actions, 7 were upgrades and 11 were downgrades. 16 analysts currently cover HSTM.
Analyst Recommendation Trends
HSTM analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$291M
↓ 11.1% YoY
Revenue Next Year
$301M
↑ 3.3% YoY
EPS This Year
$0.63
EPS Next Year
$0.63
↑ 1.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast HSTM EPS of $0.63 for the current fiscal year, based on estimates from 3 analysts. The HSTM revenue forecast is $291M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The HSTM stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus HSTM price target is $24.00 (-6.2% upside), with an analyst consensus of Hold.
The HSTM short-term stock prediction for tomorrow is $26.26 (+2.61%). The HSTM stock price prediction for 2027 estimates an average of $25. The HSTM stock prediction for 2030 projects a range of $22–$25.
HealthStream, Inc. trades on NASDAQ under the ticker HSTM. The HSTM stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 44% of covering analysts.
Frequently asked questions
HSTM forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month HSTM price target is $24.00, with a high forecast of $24.00 and a low of $24.00. The median price target is shown in the chart above when available. This implies -6.2% potential upside from the current price of $25.59.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.